Rnj, (Translation) MD. 036/2020 February 26, 2020 Re: Management Discussion and Analysis For the Year Ended December 31, 2019 To: President The Stock Exchange of Thailand Management Discussion and
: Management discussion and analysis for the year ended December 31, 2017 To Director and Manager of the Stock Exchange of Thailand Referring to the submission of the audited financial statements of Wiik
Management Discussion and Analysis for the second quarter ended June 30, 2019 Attention The President The Stock Exchange of Thailand Attachment Report and interim financial statement for the second quarter
November 12, 2004 1/5 No: SN. 064/2019 Aug 9, 2019 Subject: Clarification of Operating Results and Financial Status of Quarter 3 ended June 30, 2019 Attention: President The Stock Exchange of
Page 1 of 4 No. RJH – SET 11/2019 13 August 2019 Subject : Management’s Discussion and Analysis for the 2nd Quarter of 2019 To : The President The Stock Exchange of Thailand Rajthanee Hospital Public
Page 1 No. VRS_11/2562 Date 14 August 2019 Subject: Management Discussion and Analysis for the quarter ended 30 June 2019 To Director and Manger The Stock Exchange of Thailand Veranda Resort Public
-1- AIT (VP-SEC) 018E/2018 August 9, 2018 Subject: Management's Discussion and Analysis of Operating Results for Q2-2018 To: The President of The Stock Exchange of Thailand Summary of Operations Q2
and Analysis for the three-month period ended 30 Jun. 2018 To : Director and the President The Stock Exchange of Thailand Summary of the Company’s Financial Position and Operating Result for the 3 and 6
[COMPANY NAME] Ref.: EFORL IR 036/2019 November 14, 2019 Subject: Management Discussion and Analysis Quarter 3 Ending 30 September 2019 To President The Stock Exchange of Thailand 1. Overview
, Samutsakhon 74000 No. DOD43/2563 May 14, 2020 To: The President The Stock Exchange of Thailand (SET) Subject: Management’s Discussion and Analysis for the first Quarter of 2020 DOD Biotech Public Company